Calquence 100 mg, Filmtabletten

7680688170016 CH-68817 Filmtabletten

Associated product:

CALQUENCE cpr pell 100 mg 60 pce
Calquence 100 mg, Filmtabletten
Calquence 100 mg, Filmtabletten
Calquence 100 mg, Filmtabletten
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/10/2025
Patient information leaflet
Français
21/10/2025
Patient information leaflet
Italien
21/10/2025
Summary of Product Characteristics
Allemand
21/10/2025
Summary of Product Characteristics
Français
21/10/2025
Summary of Product Characteristics
Italien
21/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
0.59 MG Substance HBESI

Reimbursement information

Public price
CHF 4745.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2023

Authorization holder

AstraZeneca AG

6340 Baar

Authorization information

Swissmedic authorization number
68817
Drug name
Calquence, Filmtabletten
Galenic form
FILM
ATC Code
L01EL02
Authorization status
Z
Dispensing category
A
First authorization
04/05/2023
Authorization expiration date
03/05/2028
IT Number
07.16.1.
Domain
Human medicine
Field of application
chronisch lymphatische Leukämie (CLL), Mantelzell-Lymphom (MCL)

Package details

Description (FR)
CALQUENCE cpr pell 100 mg 60 pce
Description (DE)
CALQUENCE Filmtabl 100 mg 60 Stk
Market launch
04/05/2023
Narcotic (BTM)
No